Citation: | LIAN Shengnan, SUN Jingfang, SUN Kaoxiang, LIU Wanhui, CHEN Daquan. Preparation and characterization of oligomeric hyaluronic acid-ketal as a tumour CD44 receptor and pH-sensitive targeting carrier[J]. Journal of China Pharmaceutical University, 2014, 45(5): 540-543. DOI: 10.11665/j.issn.1000-5048.20140506 |
[1] |
Morra M.Engineering of biomaterials surfaces by hyaluronan[J]. Biomacromolecules,2005,6(3):1 205-23.
|
[2] |
Stern R,Asari AA,Sugahara KN.Hyaluronan fragments:an information-rich system[J]. Eur J Cell Biol,2006,85(8):699-715.
|
[3] |
Gerecht S,Burdick JA,Ferreira LS,et al.Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells[J]. Proc Natl Acad Sci USA,2007,104(27):11 298-11 303.
|
[4] |
Yu Q,Toole BP,Stamenkovic I.Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function[J]. J Exp Med,1997,186(12):1 985-1 996.
|
[5] |
Yasuda M,Tanaka Y,Fujii K,et al.CD44 stimulation down regulates Fas expression and Fas mediated apoptosis of lung cancer cells[J].Int Immunol,2001,13(10):1 309-1 319.
|
[6] |
Wang YZ,Cao ML,Liu YW,et al.CD44 mediates oligosaccharides of hyaluronan-induced proliferation,tube formation and signal transduction in endothelial cells[J]. Exp Biol Med,2011,236(1):84-90.
|
[7] |
Yang C,Cao M,Liu H,et al.The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering[J]. J Biol Chem,2012,287(51):43 094-43 107.
|
[8] |
Toole BP.Hyaluronan:from extracellular glue to pericellular cue[J]. Nat Rev Cancer,2004,4(7):528-539.
|
[9] |
Jaracz S,Chen J,Kuznetsova LV,et al.Recent advances in tumor-targeting anticancer drug conjugates[J]. Bioorg Med Chem,2005,13(17):5 043-5 054.
|
[10] |
Götte M,Yip GW.Heparanase,hyaluronan,and CD44 in cancers:a breast carcinoma perspective[J].Cancer Res,2006,66(21):10 233-10 237.
|
[11] |
Choi KY,Min KH,Yoon HY,et al.PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo[J]. Biomaterials,2011,32(7):1 880-1 889.
|
[12] |
Heffernan MJ,Murthy N.Polyketal nanoparticles:a new pH-sensitive biodegradable drug delivery vehicle[J].Bioconjug Chem,2005,16(6):1 340-1 342.
|
[1] | HOU Yurong, FAN Qingfeng, SHI Sunliang, YUAN Yaozuo, ZHANG Mei. Determination of the content of sisomicin sulfate and sodium chloride injection by RP-HPLC[J]. Journal of China Pharmaceutical University, 2018, 49(6): 695-698. DOI: 10.11665/j.issn.1000-5048.20180609 |
[2] | YAN Zhengyu, SHU Juan, YU Yan, ZHANG Zhengwei, TANG Lu, CHEN Jianqiu. Preparation and application of carbon dots in chloramphenicol determination[J]. Journal of China Pharmaceutical University, 2015, 46(3): 322-327. DOI: 10.11665/j.issn.1000-5048.20150310 |
[3] | ZHONG Wen-ying, HUANG Bin, CHEN Lin, SHU Chang. Fluorescence resonance energy transfer quenching for determination of vitamin B2[J]. Journal of China Pharmaceutical University, 2011, 42(6): 527-533. |
[4] | Determination of Cyclosporin A in Ocular Tissues by HPLC-MS[J]. Journal of China Pharmaceutical University, 2003, (4): 44-47. |
[5] | Content Determination and Stability Research on Diclofenac-Zn[J]. Journal of China Pharmaceutical University, 2002, (3): 92-93. |
[6] | Determination of Contents of Dextromethorphan Hydrobromide and Guaifenesine in Capsules by HPLC[J]. Journal of China Pharmaceutical University, 1999, (5): 367-369. |
[7] | Determination of Norgestrel in Compound Preparation by First Derivative Spectrography[J]. Journal of China Pharmaceutical University, 1995, (4): 246-247. |
[8] | HPLC Determination of Diclofenac in Transdermal Receiver Solution[J]. Journal of China Pharmaceutical University, 1994, (6): 342-344. |
[9] | A Reversed-Phase HPLC Method for the Determination of Paeoniflorin Content[J]. Journal of China Pharmaceutical University, 1994, (4): 46-48. |
[10] | Study on the Content of Tetrahydropalmatine in Corydalis Yanhusuo by SLS-micellar Enhanced Fluorometry[J]. Journal of China Pharmaceutical University, 1993, (6): 345-347. |